Table 3.
Solutions for | Solutions for | |
---|---|---|
Outlet-Related | Bladder-Related | |
Therapeutic Approach | Disorders (SUI) | Disorders (UUI) |
Absorbent products | ✓ | ✓ |
Artificial sphincter | ✓ | |
Behavioral therapy* | ✓ | ✓ |
Bladder overdistention | ✓ | |
Bladder outlet reconstruction | ✓ | |
Closure of bladder outlet | ✓ | |
Continuous catheterization | ✓ | ✓ |
Electrical stimulation | ✓ | ✓ |
External collecting device | ✓ | ✓ |
Interruption of innervation, central | ✓ | |
Interruption of innervation, peripheral | ✓ | |
Occlusive devices | ✓ | |
Pharmacologic therapy | ||
α-Adrenergic agonists | ✓ | |
α-Adrenergic antagonists | ✓ | |
Anticholinergics | ✓ | |
β-Adrenergic agonists | ✓ | ✓ |
β-Adrenergic antagonists | ✓ | |
Calcium antagonists | ✓ | |
Capsaicin, resiniferatoxin | ✓ | |
Dimethyl sulfoxide | ✓† | |
Estrogen | ✓ | ✓ |
SNRIs | ✓ | ✓ |
Urinary diversion | ✓ | ✓ |
Behavioral therapy consists of education, fluid restriction, bladder training, timed voiding, and pelvic floor muscle training, with or without biofeedback.
Interstitial cystitis only.
SUI, stress urinary incontinence; UUI, urge urinary incontinence; SNRIs, serotonin-norepinephrine reuptake inhibitors.
Adapted from Wein AJ, Rovner ES. Urol Clin North Am. 2000;29:537–550.8